# OLANZAPINE

NDC: 68462-952
Generic name: OLANZAPINE
Labeler / Manufacturer: GLENMARK PHARMACEUTICALS INC., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20260305

FDA application: ANDA220323

## Active ingredients

- OLANZAPINE: 10 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-952"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-952
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e709eaf-4116-4ee3-8dff-ace36181d115